Mary D Chamberlin

9PUBLICATIONS
73CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Psychosocial aspects of childbirth and perinatal mental healthPredictive and prognostic markersCommunication studiesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 17, 2026
Decentralizing Post-Treatment Follow-Up for Cervical Cancer in Rwanda: Perspectives of Survivors and Clinicians.

|Mar 26, 2026
Referral Patterns and Delays in the Care of Patients With Breast Complaints in Rwanda: A Cohort Study From a Tertiary Hospital.

Vincent Kwizera, Benitha Rangira, Brandon A Niyibizi

|Jan 08, 2025
Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy-Tolerant Persister Cells in ER+ Breast Cancer.

Steven Tau, Mary D Chamberlin, Huijuan Yang

|Sep 21, 2023
Enhancing Efficiency and Reach Using Facebook to Recruit Breast Cancer Survivors for a Telephone-Based Supportive Care Randomized Trial During the COVID-19 Pandemic.

Deborah B Ejem, Stephen Wechsler, Sarah Gallups

|Sep 21, 2023
Near-Infrared Spectral Tomography for Predicting Residual Cancer Burden during Early-Stage Neoadjuvant Chemotherapy for Breast Cancer.

Xu Cao, Kristen E Muller, Mary D Chamberlin

|Jun 01, 2023
Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer.

Gary N Schwartz, Peter A Kaufman, Karthik V Giridhar

Pageof 2

Frequent Collaborators

2 joint publications

Jonathan D Marotti

2 joint publications

Eugene Demidenko

2 joint publications

Shannon M Soucy

2 joint publications

Peter A Kaufman